Rescriptor Drug Information

Browse eMedTV's wide range of articles related to rescriptor drug information including topics such as rescriptor and pregnancy, rescriptor warnings and precautions, and rescriptor dosage. Use the search box at the top-right corner of the page to find information about other health topics.

Description of Articles in Rescriptor Drug Information

Rescriptor is a prescription medicine that is licensed for treating HIV and AIDS. This article on the eMedTV Web site describes the drug in detail, including information on its effects, dosing guidelines, and possible side effects.

Fever, diarrhea, and fatigue are some of the common side effects that have been reported with Rescriptor. This eMedTV segment lists additional Rescriptor side effects, including serious ones that may require prompt medical attention.

Rescriptor is used for treating HIV and AIDS in people as young as 16 years old. This part of the eMedTV library offers more information on Rescriptor uses and explains whether the medication is used off-label for other conditions.

For HIV or AIDS treatment, the recommended Rescriptor dosage is 400 mg three times a day. This page from the eMedTV archives offers other Rescriptor dosing guidelines and includes precautions and tips for those taking the medication.

Medicines that may cause Rescriptor drug interactions include cyclosporine, rifabutin, and trazodone. This eMedTV page offers a more complete list of drugs that can interact with Rescriptor and describes the possible effects of these interactions.

Stomach acid is necessary for the absorption of Rescriptor into the bloodstream. This eMedTV segment offers other important information about Rescriptor. Warnings and precautions on who should not take the medicine are also included.

A Rescriptor overdose will most likely cause the usual side effects. As this eMedTV segment explains, not much is known about what to expect with an overdose, but treatment may involve certain drugs, "pumping the stomach," or supportive care.

At this time, it is not known whether Rescriptor is safe for use during pregnancy. This eMedTV article contains more information on Rescriptor and pregnancy, and explains the problems that occurred when the drug was given to pregnant animals.

It is generally considered unsafe to use Rescriptor while breastfeeding. This part of the eMedTV Web site offers more information on Rescriptor and breastfeeding, and discusses the risks of nursing a child if you have HIV or AIDS.

Rescriptor is not yet available in generic form. The drug, as this eMedTV page explains, is currently protected by a patent that prevents any generic versions from being made. When the patent expires in 2013, generic Rescriptor may be available.